Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping BasketShopping Basket
+44 (0) 203 086 8600 Call us on

Gastrointestinal Pharmaceuticals: Technologies and Markets

3886.43

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

£3,886.43

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

1 September 2009

Number of Pages

176

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

BCC Research

File Format

PDF

- Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.

- The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.


This study is presented to heighten the awareness of gastrointestinal disorders and identify pharmaceutical preparations and important advancements in the gastrointestinal markets. The study analyzes therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact on the future of both the prescription gastrointestinal drug market and the over-the-counter (OTC) gastrointestinal drug market.

Manufacturers of gastrointestinal drug products have stepped up the pace of research and development as the engine driving growth in all markets, especially new treatments for Crohns disease and irritable bowel syndrome (IBS). Because of the evolving nature of the many areas of gastrointestinal disorders, executives involved in the specific areas within the gastrointestinal drug market must remain ever vigilant of the changing environment and strive to keep abreast of current and potential opportunities within the gastrointestinal marketplace.

INTENDED AUDIENCE

The information and analyses presented in this report are important assets in decision-making for managers involved in business development, marketing, market research, product development, mergers and acquisitions, licensing, business management, investment banking and deal creation, and for consultants to the pharmaceutical and biotechnology industry. The study provides a comprehensive analysis of the current markets for gastrointestinal drugs and, in particular, the market potential of technologies in development.

SCOPE OF REPORT

This report is designed to be a comprehensive business tool to provide an in-depth look at gastrointestinal disorders. The geographic scope of the report is global with a particular emphasis on the United States. Market data is global. The report provides an overview of the gastrointestinal system; gives a brief explanation of disorders of the gastrointestinal system; cites risk factors, where applicable; cites incidence and mortality; presents current pharmaceutical treatments, market size and market participants in both prescription and OTC arenas; and presents potential treatments in research and development, potential market size, and market participants. This report describes the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.

Within the market for gastrointestinal pharmaceuticals, categories are divided into two general segments:

* Prescription gastrointestinal pharmaceuticals
* Over-the-counter gastrointestinal pharmaceuticals

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system including the following:

* Gastrointestinal tract disorders
* Gastrointestinal tract wall disorders
* Gastrointestinal motility disorders
* Gastrointestinal malabsorption disorders
* Gastrointestinal cancers

Each sub segment is addressed in detail, describing disorders and the diseases, identifying current and potential products on the market, and competitors involved in the market.

 

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

£3,886.43

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings